HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis

Figure 1

The expression level of HDAC10 is relevant to the severity of lesions and downregulated in cervical carcinoma. (a) Detecting HDAC10 mRNA expression level in cervical cancer, HSIL, LSIL, and normal tissues by RT-qPCR. (b) Quantification of the protein expression level of HDAC10 in cervical carcinoma tissues and normal tissues. (c) Expression level of HDAC10 in cervical carcinoma cell lines (HeLa and Siha) and VK2 cells. (d) Expression level of HDAC10 protein in cervical carcinoma tissue and normal tissues. (e) Expression of HDAC10 in tumor and normal tissues based on the CESC-TCGA database. (f) The overall survival analysis among women with different HDAC10 expression levels based on the CESC-TCGA database.

(a)

(b)

(c)

(d)

(e)

(f)